Kiss, Szilárd <br/><br/>
Management and Outcomes for Neovascular Age-Related Macular Degeneration: Analysis of United States Electronic Health Records.  [electronic resource] 

 -  Ophthalmology  09 2020 
 - 1179-1188 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-4713 
<br/><br/><label>Standard No.: </label>10.1016/j.ophtha.2020.02.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--therapeutic use<br/>Bevacizumab--therapeutic use<br/>Choroidal Neovascularization--drug therapy<br/>Cohort Studies<br/>Electronic Health Records--statistics & numerical data<br/>Female<br/>Fluorescein Angiography<br/>Humans<br/>Intravitreal Injections<br/>Male<br/>Ranibizumab--therapeutic use<br/>Receptors, Vascular Endothelial Growth Factor--therapeutic use<br/>Recombinant Fusion Proteins--therapeutic use<br/>Retrospective Studies<br/>Treatment Outcome<br/>United States<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--physiology<br/>Wet Macular Degeneration--drug therapy